FLR
36
-3
F
42
-4
DAL
48
-2
HAL
41
11
LYB
32
2
ILMN
36
10
SJM
29
-2
PRU
50
2
CF
38
-3
WFC
58
-3
GM
61
-4
GWW
46
2
NVDA
60
-5
UAL
34
-3
DG
32
-2
KHC
29
2
KLAC
65
-2
MHK
40
-6
ADT
55
25
GILD
50
13
FLR
36
-3
F
42
-4
DAL
48
-2
HAL
41
11
LYB
32
2
ILMN
36
10
SJM
29
-2
PRU
50
2
CF
38
-3
WFC
58
-3
GM
61
-4
GWW
46
2
NVDA
60
-5
UAL
34
-3
DG
32
-2
KHC
29
2
KLAC
65
-2
MHK
40
-6
ADT
55
25
GILD
50
13
Financhill
Back

Pliant Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
45

PLRX
Pliant Therapeutics

Last Price:
10.98
Seasonality Move:
50.54%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
45
Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics a Buy, Sell or Hold?

  • The current Pliant Therapeutics [PLRX] share price is $10.99. The Score for PLRX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • PLRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PLRX Stock Price Chart

What is Pliant Therapeutics's stock price today?

  • The Pliant Therapeutics share price today is $10.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PLRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 36.03 Sell
Chaikin Money Flow: 25532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.06 - 13.88) Sell
Bollinger Bands (100): (12.4 - 16.14) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

PLRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.31 Sell
20-day SMA: 11.84 Sell
50-day SMA: 12.82 Sell
200-day SMA: 15.08 Sell
8-day EMA: 11.23 Sell
20-day EMA: 11.87 Sell
50-day EMA: 12.84 Sell
200-day EMA: 15.32 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Pliant Therapeutics Earnings Growth & PLRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.27 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Pliant Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):